Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Open-Label Multicenter Community-based 4-Wk Trial to Assess Efficacy, Tolerance to Tx & Patient Satisfaction w/ CLOBEX® Spray When Used as Mono- or Add-on Therapy to Existing Systemic/Topical Agents for Tx of Plaque Psoriasis

NCT00437216 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT00437216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00437216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Open-Label Multicenter Community-based 4-Wk Trial to Assess Efficacy, Tolerance to Tx & Patient Satisfaction w/ CLOBEX® Spray When Used as Mono- or Add-on Therapy to Existing Systemic/Topical Agents for Tx of Plaque Psoriasis
Lead sponsor
Galderma R&D
Phase
Observational
Overall status
Completed
Start date
February 28, 2006
Completion date
July 31, 2006
Enrollment
2,488 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis